<DOC>
	<DOCNO>NCT00353808</DOCNO>
	<brief_summary>The purpose study ass long-term safety tolerability [ S , S ] -Reboxetine patient chronic pain follow shingle . This extension study Protocol A6061026 .</brief_summary>
	<brief_title>A Trial Assessing The Long Term Safety And Tolerability Of S , S-Reboxetine In Patients With Post-Shingles Pain .</brief_title>
	<detailed_description />
	<mesh_term>Reboxetine</mesh_term>
	<criteria>Patients must meet patient selection criterion precede doubleblind Protocol A6061026 complete 16week trial . Patients screen must score &gt; /=40mm pain visual analogue scale . Serious adverse event precede doubleblind Protocol A6061026 determine related trial medication Investigator . Patient treatment compliance le 80 % precede doubleblind Protocol A6061026 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>